Delivery Order SPE2DB22D9207-SPE2DB25FH5CT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on August 22, 2025, carries a ceiling value of $34,149.62 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. This award does not utilize a set-aside designation, and the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract, awarded on September 17, 2025, carries a ceiling value of $15,063.78 and operates under a firm fixed-price structure with an ultimate completion date of October 8, 2025. This delivery order was issued without set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on August 27, 2025, carries a ceiling value of $5,021.26 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This award was made without a set-aside designation, demonstrating the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 17, 2025. The contract calls for delivery of EXPAREL 266 mg/20 ml vials and is structured as a firm fixed-price delivery order with an ultimate completion date of October 8, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The contract, awarded on September 26, 2025, carries a ceiling value of approximately $30,128 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. This award was made without a set-aside designation, allowing the vendor to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $30,127.56 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 ml vials on September 2, 2025. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, and the product will be supplied to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,487.22 firm-fixed-price contract is for the supply of EXPAREL 266 MG/20 ML vials. This delivery order is part of a larger indefinite delivery contract, SPE2DB-13-D-4600, held by DMS Pharmaceutical Group with DLA, valued up to $4,999,999 through 2025. The IDV enables DLA to issue delivery orders for a broad range of...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract was awarded on August 25, 2025, with a firm fixed-price ceiling value of $6,028.88 and an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $12,553.15 and an ultimate completion date of August 4, 2025. This award was made without a set-aside designation, and the place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group is...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5CTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on July 29, 2025, carries a ceiling value of $25,106.30 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was made without a set-aside designation, and the place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA through the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare facilities worldwide. EXPAREL, a liposomal bupivacaine injection used for local anesthesia, represents one of the specialized pharmaceutical products within the broader contract portfolio that includes prescription medications, biologics, and medical consumables essential to Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 7/29/25 |